Skip to main content
SpringerLink
Log in

Clinical assessment of carcinoma in situ of the human urinary bladder

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Recent interest in intravesical instillation of bacillus Calmette-Guérin for the management of carcinoma in situ (CIS) of the bladder prompted us to review our results of total immediate cystourethrectomy. From 1975 to 1987, we surgically treated 302 patients with primary bladder tumours. Of these, 21 bladder tumours were histologically diagnosed as CIS, and total immediate cystourethrectomy was performed in all cases. The lesions were classified into three types: primary CIS accompanied by neither previous nor simultaneous tumours of the urinary tract (Type 1,9 patients), concomitant CIS associated with superficial papillary tumour (Type 2, 6 patients), and secondary CIS detected during the follow-up period after treatment of the superficial papillary tumour (Type 3, 6 patients). Primary CIS was more often diagnosed according to subjective symptoms such as micturition patin than concomitant CIS. Secondary CIS was diagnosed in all patients by routine examinations including cytology and cystoscopy. There was no particular relationship between the time of recurence of the tumour and the occurrence of secondary CIS. Within the same period, 60 patients with stage T1 bladder tumour were treated by total cystourethrectomy. The actuarial 5-year survival rate was 77% for T1 and 75% for CIS. The 5-year survival rate was 71% for Type 1, 83% for Type 2, and 67% for Type 3 CIS with no difference among the CIS types.

Tumour invasion to the bladder, prostate, ureter, or lymph nodes was observed in 9 (42.9%) of the 21 patients, although cystourethrectomy was performed within 3 months of the diagnosis. Examination of ABH antigens did not allow prediction of invasion of CIS.

Our findings suggest that the invasive potential of CIS may seriously limit the indications of conservative treatment against carcinoma in situ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Soloway, M. S.: The management of superficial bladder cancer.Cancer, 45, 1856 (1980).

    PubMed  CAS  Google Scholar 

  2. Kakizoe, T., Tobisu, K., Takai, K.: Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder.Cancer Res., 48, 2299 (1988).

    PubMed  CAS  Google Scholar 

  3. Tsujihashi, H., Matsuda, H., Uejima, S., Kurita, T.: Cell proliferation of human bladder tumors.J. Urol., 142, 1113 (1989).

    PubMed  CAS  Google Scholar 

  4. Tsujihashi, H., Matsuda, H., Uejima, S., Kurita, T.: The kinetics of cellular proliferation in rat urinary bladder treated with N-butyl-N-(4-hydroxybutyl) nitrosamine.J. Urol., 144, 1493 (1990).

    PubMed  CAS  Google Scholar 

  5. Morales, A., Eidinger, D., Bruce, A. W.: Intracavitary bacillus Calmette-Guérin immunotherapy of superficial bladder canceer.J. Urol., 116, 180 (1976).

    PubMed  CAS  Google Scholar 

  6. Fujita, K.: The role of adjunctive immunotherapy in superficial bladder cancer.Cancer, 59, 2027 (1987).

    Article  PubMed  CAS  Google Scholar 

  7. Tsujihashi, H., Matsuda, H., Uejima, S., Kurita, T.: Immunocompetence of tissue infiltrating lymphocytes in bladder tumors.J. Urol., 140, 890 (1988).

    PubMed  CAS  Google Scholar 

  8. Farrow, G. M., Utz, D. C., Rile, C. C.: Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy.Cancer Res., 36, 2495 (1976).

    PubMed  CAS  Google Scholar 

  9. Farrow, G. M., Utz, D. C., Greene, L. F.: Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder.Cancer Res., 37, 2794 (1977).

    PubMed  CAS  Google Scholar 

  10. Prout, G. R., Griffin, P. P., Heney, N. M.: Carcinoma in situ of the urinary bladder with and without associated vesical neoplasms.Cancer, 52, 524 (1983).

    Article  PubMed  Google Scholar 

  11. Fukui, I., Yokokawa, M., Oshima, H.: Carcinoma in situ of the urinary bladder. Effect of associated neoplastic lesions on clinical course and treatment.Cancer, 59, 164 (1987).

    Article  PubMed  CAS  Google Scholar 

  12. Brosman, S. A.: The use of bacillus Calmette-Guérin in the therapy of bladder carcinoma in situ.J. Urol., 134, 36 (1985).

    PubMed  CAS  Google Scholar 

  13. Herr, H. W., Pinsky, C. M., Melamed, M. R.: Long-term effect of intravesical bacillus Calmette-Guérin on flat carcinoma in situ of bladder.J. Urol. 135, 265 (1986).

    PubMed  CAS  Google Scholar 

  14. Stanisic, T. H., Donovan, J. M., Graham, A. R.: 5-year experience with intravesical therapy of carcinoma in situ. An inquiry into the risks of “conservative” management.J. Urol., 138 1158 (1987).

    PubMed  CAS  Google Scholar 

  15. Prout, G. R., Griffin, P. P., Daly, J. J.: The outcome of conservative treatment of carcinoma in situ of the bladder.J. Urol., 138, 766 (1987).

    PubMed  Google Scholar 

  16. Koss, L. G.: Tumors of the Urinary Bladder. Atlas of Tumor Pathology, 2nd ser., fasc. 11 (Armed Forces Institute of Pathology, Washington 1975).

    Google Scholar 

  17. Union Internationale Contre le Cancer: TNM classification of malignant tumors (Union Internationale Contre le Cancer, Geneva 1974).

    Google Scholar 

  18. Kakizoe, T., Matsumoto, K., Kishi, K.: Treatment of carcinoma in situ by total cystectomy. Histopathological analysis. tWorld J. Urol.,1, 106 (1983).

    Article  Google Scholar 

  19. Tsujihashi, H., Akiyama, T., Kurita, T.: Detection of ABH antigens via exfoliated urinary cells. A preliminary report.Urol. Int., 42, 431 (1987).

    Article  PubMed  CAS  Google Scholar 

  20. Kaplan, E. L., Meier, P.: Nonparametric estimation from incomplete observations.J. Am. Stat. Assoc., 53, 457 (1958).

    Article  Google Scholar 

  21. Kaye, K. W., Lange, P. H.: Mode of presentation of invasive bladder cancer. Reassessment of the problem.J. Urol., 128, 31 (1982).

    PubMed  CAS  Google Scholar 

  22. Ohtani, M., Kakizoe, T., Niijima, T.: Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine.Cancer Res., 46, 2001 (1986).

    PubMed  CAS  Google Scholar 

  23. Utz, D. C., Hanash, K. A., Farrow, G. M.: The plight of the patient with carcinoma in situ of the bladder.J. Urol., 123, 160 (1970).

    Google Scholar 

  24. Althausen, A. F., Prout, G. R., Daly, J. J.: Non-invasive papilary carcinoma of the bladder associated with carcinoma in situ.J. Urol., 116, 575 (1976).

    PubMed  CAS  Google Scholar 

  25. Winstein, R. S., Miller, A. W., Pauri, B. U.: Carcinoma in situ. Comments on the pathobiology of a paradox.Urol. Clin. North Am., 7, 523 (1980).

    Google Scholar 

  26. Haaf, E. O., Ratliff, T. L., Catalona, W. J.: Two courses of intravesical bacillus Calmette-Guérin for transitional cell carcinoma of the bladder.J. Urol., 136, 820 (1986).

    Google Scholar 

  27. Emmott, R. C., Droller, M. J., Javadpour, N.: Studies of A, B or O(H) surface antigen specificity. Carcinoma in situ and non-malignant lesions of the bladder.J. Urol.,125, (1981).

  28. Herr, H. W., Whitmore, W. F., Pinsky, C. W.: Extravesical Carcinoma in situ after Intravesical Bacillus Calmette-Guérin (BCG). Read at Annual Meeting of American Urological Associations. Las Vegas, Nevada, April 17–21, 1983. Abstract 346, p. 178.

  29. Herr, H. W., Whitmore, W. F.: Ureteral carcinoma in situ after successful intravesical therapy for superfical bladder tumors. Incidence, possible pathogenesis and management.J. Urol., 138, 292 (1987).

    PubMed  CAS  Google Scholar 

  30. Schellhammer, P. E., Bean, M. A., Whitmore, W. F.: Prostatic involvement by transitional cell carcinoma. Pathogenesis, patterns and prognosis.J. Urol., 118, 399 (1977).

    PubMed  CAS  Google Scholar 

  31. Hardeman, S. W., Perry, A., Soloway, M. S.: Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder.J. Urol., 140, 289 (1988).

    PubMed  CAS  Google Scholar 

  32. Wood, D. P., Montie, J. E., Levin, H. S.: Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.J. Urol., 141, 346 (1989).

    PubMed  Google Scholar 

  33. Droller, M. J., Walsh, P. C.: Intravesical chemotherapy in the treatment of flat carcinoma in situ. Is it safe?J. Urol., 134, 1115 (1985).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Kinki University School of Medicine, Osaka, Japan

    H. Tsujihashi, A. Nakanishi, H. Matsuda, S. Uejima, T. Akiyama & T. Kurita

Authors
  1. H. Tsujihashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Nakanishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Matsuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Uejima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Akiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. Kurita
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsujihashi, H., Nakanishi, A., Matsuda, H. et al. Clinical assessment of carcinoma in situ of the human urinary bladder. International Urology and Nephrology 24, 243–254 (1992). https://doi.org/10.1007/BF02549532

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02549532

Keywords

Search

Navigation